10 Best Small-Cap Stocks to Buy According to Billionaires

4. Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Market Capitalization: $1.82 Billion

Number of Billionaire Investors: 11

Number of Hedge Fund Holders: 47

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best small-cap stocks to buy according to billionaires. On June 25, Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported that it received approval for Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for the treatment of adults with late-onset Pompe disease (LOPD) from Japan’s Ministry of Health, Labour and Welfare (MHLW).

According to the report by Amicus Therapeutics, Inc. (NASDAQ:FOLD), Pombiliti + Opfolda works as a two-component therapy. Pombiliti is a special enzyme designed for increased uptake into muscle cells, while Opfolda is an enzyme stabilizer that helps keep this enzyme stable in the blood.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) has now received approvals for Pombiliti + Opfolda in the United States, the European Union, the United Kingdom, Canada, Australia, Switzerland, and Japan.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is an American biopharmaceutical company that discovers, develops, and delivers novel medicines for people living with rare diseases.